EP1361834B1 - Tension-free elastic tape - Google Patents
Tension-free elastic tape Download PDFInfo
- Publication number
- EP1361834B1 EP1361834B1 EP02718107A EP02718107A EP1361834B1 EP 1361834 B1 EP1361834 B1 EP 1361834B1 EP 02718107 A EP02718107 A EP 02718107A EP 02718107 A EP02718107 A EP 02718107A EP 1361834 B1 EP1361834 B1 EP 1361834B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tape
- tape according
- threads
- band
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000001519 tissue Anatomy 0.000 claims abstract description 21
- 239000004753 textile Substances 0.000 claims abstract description 16
- 238000004873 anchoring Methods 0.000 claims abstract description 10
- 210000002808 connective tissue Anatomy 0.000 claims abstract description 10
- 206010046543 Urinary incontinence Diseases 0.000 claims abstract description 5
- 238000001356 surgical procedure Methods 0.000 claims abstract description 5
- 239000004744 fabric Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 16
- 239000002131 composite material Substances 0.000 claims description 10
- 238000004026 adhesive bonding Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000003466 welding Methods 0.000 claims description 2
- -1 z. B. as in jersey Substances 0.000 description 11
- 238000005520 cutting process Methods 0.000 description 10
- 230000007794 irritation Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000007688 edging Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001643 poly(ether ketone) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B21/00—Warp knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B21/20—Warp knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting articles of particular configuration
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B21/00—Warp knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B21/14—Fabrics characterised by the incorporation by knitting, in one or more thread, fleece, or fabric layers, of reinforcing, binding, or decorative threads; Fabrics incorporating small auxiliary elements, e.g. for decorative purposes
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/08—Hernia repair mesh
Definitions
- the invention relates to a tensile elastic band for the operative treatment of urinary incontinence of the woman according to the preamble of claim 1.
- This known band has a relatively high rigidity on, which can complicate the feeding of the tape.
- the Tape is cut as a strip of textile sheet material. This results in the longitudinal edges of the band free monofilament ends. When feeding the band favor These free ends provide a primary anchoring of the band in the fabric.
- the cutting of the textile sheet material leads in the production of the tapes to a disintegration of the stitches at the wall edges, so that at the edge during the Insertion and also postoperatively peel off particles. Either the protruding monofilament ends as well as severed, in particular sharp-edged monofilament particles can be permanent Cause inflammation.
- the separation of the edge stitch is reduced
- the strength of the band resulting in an increased Material use must be compensated.
- the invention is based on the object, a band available to provide, which eliminates the problems mentioned or reduced and in particular a good primary anchorage with a minimal tissue irritation combined.
- That for the operative treatment of urinary incontinence of the woman suitable band is dimensioned so that its length is essential bigger than its width, for example more than that Twenty times the width.
- a band for example, a length of 450mm and a width of 10mm exhibit.
- the essential idea of the invention is that of the Longitudinal edges of the strip to provide edge threads, on the one hand sticking out of the textile composite of the band to get a good To ensure primary anchoring of the band, and that themselves On the other hand, it does not come loose from the textile structure of the band.
- the selvage threads thereby form loops which have a relatively large opening, so that the fabric can penetrate directly into the openings of these loops and a fast and good primary anchoring is effected.
- the permanent stabilization of the band in the tissue can be favored by these loops.
- the opening of the loops preferably has a size of more than 0.01 mm 2 , preferably from 0.02 to 1 mm 2 .
- the loops are integrated into the textile composite of the band so that they can not be detached from the band. Since the loops have no free ends, they cause no irritation of the tissue, which could lead to permanent inflammation.
- a fabric is used whose width is several times the width of the single band corresponds and that in the individual bands is divided. It is advantageous, compared to the for the bands provided composite deviating indentations by remaining free Lochnadeln provide, in the area of this sheet to be separated into the individual bands. Thereby is a simple separation, especially a machine Disconnect possible.
- the separation can be different Way done, z. B. by chemical or physical action. It can be a cutting process by means of a mechanical Cutting edge, by means of a thermal cutting wire or by means of an ultrasonic cutting device are performed.
- the Thermal cutting and ultrasonic cutting in particular the advantage that the severed threads that the Edge threads of the bands form, with suitable process control have no sharp-edged separation points.
- edged filaments are to be severed Edged threads made from a resorbable filament.
- the band must have sufficient tensile stability to be able to move in streamlined condition to support the urethra. Likewise, that must Band have sufficient elasticity to the anatomical Give way to tissue movements and be able to follow.
- the textile composite of the band is preferably designed as a knitted fabric, z. B. as in jersey, cloth and velvet binding. The mesh size is chosen so that a good ingrowth connective tissue into the textile structure is possible.
- the knit terry toweling executed so that both the Primärverhakung as also the ingrowth of tissue is favored.
- the band can be mainly or exclusively monofilament or be formed of multifilaments. It can for the entire Band will use the same filament material. Consists the band of a non-absorbable material, so the band remains permanently as a supporting matrix in the tissue. If adequate connective tissue proliferation is to be expected, so also a resorbable material can be used. The band then dissolves and is reabsorbed if that Connective tissue has again achieved sufficient stability.
- the mechanical properties of the tape become.
- the edge threads can consist of a resorbable material. These border threads serve primarily for the primary anchoring of the tape during and after the operation. Once the tape is sprouted connective tissue is permanently anchored, the edge threads be absorbed. This causes a tissue irritation the edge threads permanently excluded.
- the band may have a low Have mesh size made up of the resorbable and gives the non-absorbable filaments. This is one high stabilization effect of the tape ensured.
- the subsequent absorption of resorbable filaments remains then tape with the larger stick width of the remaining ones non-absorbable filaments, allowing a good ingrowth connective tissue in the band is favored.
- a rough surface e.g. terry toweling or the augmented Scarring due to absorbable sutures may be in the range of Bubble be undesirable.
- This is preferred by a change the bond over the implant length solved. For example, becomes the anchoring area is formed by a terry tie, while in the area of the bladder e.g. a tricot tie or a Fleet is executed.
- all thread-forming biocompatible polymers be used. These are from the group of non-absorbable Polymers namely polyethylene PE, polypropylene PP, polyester (e.g., polyethylene terephthalate PET and polybutylene terephthalate PBT), polyvinylidene fluoride PVDF, polytetrafluoroethylene PTFE and other fluorine-containing polymers as well Polyurethanes PUR, polyether ketones and polyphenylene sulfide.
- the absorbable polymers are preferably selected from the group of alpha and beta hydroxycarboxylic acids chosen.
- suitable Short-term resorbable polymers such as polyglycolic acid PGA.
- Slow-absorbing polymers such as polylactides can also be used.
- the implant sterilized by ionizing radiation shall be.
- copolymers and terpolymers are mutually exclusive and with elastifying components such as caprolactone and trimethylene carbonate suitable.
- polyesteramides or other resorbable biocompatible thread-forming Polymer materials are also suitable. The absorption time of these materials can with the well-known methods of ionizing Radiation are affected, at the same time a sterilization of the band to be implanted.
- the primary anchorage serving looped or hooked Outstanding edge threads would be in the operation hampering the passage of the tape through the tissue and to cause additional traumatization of the tissue. Therefore is the tape for insertion into the tissue, preferably with a enclosed tubular casing after placing of the band can be easily removed, as is itself already known from US 5,899,909.
- the hose may consist of any biocompatible material for a short time, for example, from one used for the manufacture of catheters Material (e.g., polyamide, polypropylene, polyethylene, Polyvinyl chloride).
- the Cover removed lengthwise from the tape.
- the Sheath preferably in the central region of its longitudinal extent be provided with a predetermined breaking perforation or can as open decision to be placed around the band.
- the band is preferably transmitted by atraumatic needles pulled the tissue.
- Particularly preferred are reusable Needles.
- the adapter mechanism Can be screwed, Luerlock, bayonet lock or snap connection. He insists from a biocompatible solid material, preferably from a polymeric Construction material, such as Polyamide, polyoxymethylene, Polyether ketone, polypropylene, polyethylene or polyester.
- the tape and possibly the case are with the adapter by welding, gluing, clamping or a shrink tube connected. In a particularly preferred embodiment are the adapters directly to the tape and possibly the Cover molded.
- the band of basic threads 1 is knitted in a modified tricot binding.
- the knit is supplemented in the edge region by another bond so that each edge threads 2 form at the two longitudinal edges of the band loops that protrude laterally beyond the edge of the tape.
- the loops of the edge threads 2 have an opening area of about 0.02 to 1.0 mm 2 . Since the edge yarns 2 are included in the knit of the ground yarns 1, they are firmly connected to the band. Since the edge threads 2 have no open ends, they do not cause injury or irritation of the tissue. However, the large loops of the edge threads 2 'cause a secure primary anchoring of the tape when pulled into the fabric. The large openings of the loops of the edge threads 2 also favor the ingrowth of the tissue into the structure of the band and thus a permanent anchoring of the band in the tissue.
- the ground threads 1 are as fringes formed, forfeited by part weft threads 3 to ribbons are.
- These bands are by connecting threads 4 connected to each other to the sheet.
- the connecting threads 4 between the individual bands severed along dividing lines 5.
- the severing of the connecting threads 4 is preferably carried out by ultrasonic cutting or by thermal cutting, whereby the cut edges of the then remaining free ends of the connecting threads 4 rounded become.
- the connecting threads 4 After severing the connecting threads 4 and thus the Separating the bands, the connecting threads 4 form the Edging threads of the band.
- the severed free ends of this Edging threads protrude from the composite of the tapes and form Hooks effective for the primary anchoring of the band.
- the rounding of the cut ends reduces the irritation the tissue through this protruding edge threads.
- Prefers the connecting threads 4 are made of soluble or absorbable Filaments formed.
- the connecting threads 4 are each over a few courses knitted into the composite of the ribbon before moving to the edge of the ribbon subsequent band are performed. This causes the connecting threads 4 by setting in several courses in the Knitted fabric of the tapes, so that they also after the Not cutting without a significant mechanical action from the fabric of the tape solve.
- the Basic threads 1 a knitted fabric.
- Edged threads 6 are in this knit integrated and projecting to large over the longitudinal edges of the tape Loops formed.
- the loops of the edged threads 6 also ensure a secure primary anchorage here, without causing irritation of the tissue.
- To a binding technology to get clean edge are the edged threads 6 additionally secured by a float 7.
Abstract
Description
Die Erfindung betrifft ein zugstabiles elastisches Band für
die operative Behandlung der Harninkontinenz der Frau gemäß
dem Oberbegriff des Anspruchs 1.The invention relates to a tensile elastic band for
the operative treatment of urinary incontinence of the woman according to
the preamble of
Die Harninkontinenz der Frau entsteht häufig durch Bindegewebsschwäche. Zur Therapie wird daher u. a. eine Operationstechnik eingesetzt, bei welcher ein zugstabiles elastisches Band eingezogen wird, welches die Urethra abstützt, das Bindegewebe festigt und als Matrix für das Einwachsen von neugebildetem Bindegewebe dient. Diese Operationstechnik ist beispielsweise in der US 5,899,909 beschrieben, in welcher auch ein für diese Operationstechnik geeignetes gattungsgemäßes Band angegeben ist.Female urinary incontinence is often caused by connective tissue weakness. For therapy is therefore u. a. a surgical technique used, in which a tensile elastic Band which supports the urethra, the connective tissue solidifies and as a matrix for the ingrowth of newly formed Connective tissue is used. This surgical technique is for example in US 5,899,909, in which also a suitable for this surgical technique generic Band is specified.
Dieses bekannte Band weist eine verhältnismäßig hohe Steifigkeit auf, die das Einziehen des Bandes erschweren kann. Das Band wird als Streifen aus einem textilen Flächenmaterial geschnitten. Dadurch ergeben sich an den Längskanten des Bandes freie Monofil-Enden. Beim Einziehen des Bandes begünstigen diese freien Enden eine Primärverankerung des Bandes im Gewebe. Jedoch führt das Durchtrennen des textilen Flächenmaterials bei der Herstellung der Bänder zu einem Auflösen der Maschen an den Wandkanten, so dass sich an der Kante während des Einsetzens und auch postoperativ Partikel ablösen können. Sowohl die abstehenden Monofil-Enden als auch abgetrennte, insbesondere scharfkantige Monofil-Partikel können dauerhafte Entzündungen verursachen. Das Auftrennen der Randmasche reduziert zudem die Festigkeit des Bandes, was durch einen erhöhten Materialeinsatz kompensiert werden muß.This known band has a relatively high rigidity on, which can complicate the feeding of the tape. The Tape is cut as a strip of textile sheet material. This results in the longitudinal edges of the band free monofilament ends. When feeding the band favor These free ends provide a primary anchoring of the band in the fabric. However, the cutting of the textile sheet material leads in the production of the tapes to a disintegration of the stitches at the wall edges, so that at the edge during the Insertion and also postoperatively peel off particles. Either the protruding monofilament ends as well as severed, in particular sharp-edged monofilament particles can be permanent Cause inflammation. The separation of the edge stitch is reduced In addition, the strength of the band, resulting in an increased Material use must be compensated.
Der Erfindung liegt die Aufgabe zu Grunde, ein Band zur Verfügung zu stellen, welches die genannten Probleme beseitigt oder reduziert und insbesondere eine gute Primärverankerung mit einer minimalen Gewebsirritation vereinigt. The invention is based on the object, a band available to provide, which eliminates the problems mentioned or reduced and in particular a good primary anchorage with a minimal tissue irritation combined.
Diese Aufgabe wird erfindungsgemäß gelöst durch ein Band mit
den Merkmalen des Anspruchs 1.This object is achieved by a band with
the features of
Vorteilhafte Ausführungen und Weiterbildungen der Erfindung sind in den Unteransprüchen angegeben.Advantageous embodiments and developments of the invention are given in the subclaims.
Das für die operative Behandlung der Harninkontinenz der Frau geeignete Band ist so dimensioniert, dass seine Länge wesentlich größer als seine Breite ist, zum Beispiel mehr als das Zwanzigfache der Breite. Typischerweise kann ein solches Band beispielsweise eine Länge von 450mm und eine Breite von 10mm aufweisen.That for the operative treatment of urinary incontinence of the woman suitable band is dimensioned so that its length is essential bigger than its width, for example more than that Twenty times the width. Typically, such a band for example, a length of 450mm and a width of 10mm exhibit.
Der, wesentliche Gedanke der Erfindung besteht darin, an den Längskanten des Bandes Kantenfäden vorzusehen, die einerseits aus dem textilen Verbund des Bandes herausragen, um eine gute Primärverankerung des Bandes zu gewährleisten, und die sich andererseits nicht aus der textilen Struktur des Bandes lösen.The essential idea of the invention is that of the Longitudinal edges of the strip to provide edge threads, on the one hand sticking out of the textile composite of the band to get a good To ensure primary anchoring of the band, and that themselves On the other hand, it does not come loose from the textile structure of the band.
In einer Ausführungsform bilden die Kantenfäden dabei Schlaufen, die eine relativ große Öffnung aufweisen, so dass das Gewebe unmittelbar in die Öffnungen dieser Schlaufen eindringen kann und eine schnelle und gute Primärverankerung bewirkt wird. Auch die dauerhafte Stabilisierung des Bandes in dem Gewebe kann durch diese Schlaufen begünstigt werden. Die Öffnung der Schlaufen weist vorzugsweise eine Größe von mehr als 0,01mm2, vorzugsweise von 0,02 bis 1mm2 auf. Die Schlaufen sind dabei in den textilen Verbund des Bandes eingebunden, so dass sie sich nicht von dem Band lösen können. Da die Schlaufen keine freien Enden aufweisen, bewirken sie keine Reizung des Gewebes, die zu dauerhaften Entzündungen führen könnte.In one embodiment, the selvage threads thereby form loops which have a relatively large opening, so that the fabric can penetrate directly into the openings of these loops and a fast and good primary anchoring is effected. Also, the permanent stabilization of the band in the tissue can be favored by these loops. The opening of the loops preferably has a size of more than 0.01 mm 2 , preferably from 0.02 to 1 mm 2 . The loops are integrated into the textile composite of the band so that they can not be detached from the band. Since the loops have no free ends, they cause no irritation of the tissue, which could lead to permanent inflammation.
In einer anderen Ausführung wird ein textiles Flächengebilde hergestellt, dessen Breite einem Mehrfachen der Breite des einzelnen Bandes entspricht und das in die einzelnen Bänder unterteilt wird. Dabei ist es vorteilhaft, gegenüber dem für die Bänder vorgesehen Verbund abweichende Einzüge durch freibleibende Lochnadeln vorzusehen, in deren Bereich dieses Flächengebilde in die einzelnen Bänder getrennt werden soll. Dadurch ist ein einfaches Trennen, insbesondere auch ein maschinelles Trennen möglich. Das Trennen kann auf unterschiedliche Weise erfolgen, z. B. durch chemische oder physikalischen Einwirkung. Es kann ein Schneidvorgang mittels einer mechanischen Schneide, mittels eines Thermoschneiddrahtes oder auch mittels einer Ultraschall-Schneideinrichtung durchgeführt werden. Das Thermoschneiden und das Ultraschallschneiden haben dabei insbesondere den Vorteil, dass die durchtrennten Fäden, die die Kantenfäden der Bänder bilden, die bei geeigneter Prozessführung keine scharfkantigen Trennstellen aufweisen. Dauerhafte Entzündungsreize werden daher durch die Kantenfäden nicht verursacht. Um zu vermeiden, dass die durchtrennten Kantenfäden sich aus dem Verbund des abgetrennten Bandes lösen; werden diese Kantenfäden mit einer langen Unterlegung in dem textilen Verbund und Abbindung in mehreren Maschenreihen ausgeführt. In einer besonders bevorzugten Ausführung bestehen die zu durchtrennenden Kantenfäden aus einem resorbierbaren Filament.In another embodiment, a fabric is used whose width is several times the width of the single band corresponds and that in the individual bands is divided. It is advantageous, compared to the for the bands provided composite deviating indentations by remaining free Lochnadeln provide, in the area of this sheet to be separated into the individual bands. Thereby is a simple separation, especially a machine Disconnect possible. The separation can be different Way done, z. B. by chemical or physical action. It can be a cutting process by means of a mechanical Cutting edge, by means of a thermal cutting wire or by means of an ultrasonic cutting device are performed. The Thermal cutting and ultrasonic cutting in particular the advantage that the severed threads that the Edge threads of the bands form, with suitable process control have no sharp-edged separation points. durable Inflammatory stimuli are therefore not caused by the edged filaments. To avoid the severed edge threads detach from the composite of the severed band; become these edge threads with a long underlay in the textile Bonding and setting executed in several courses. In In a particularly preferred embodiment, they are to be severed Edged threads made from a resorbable filament.
Das Band muß eine ausreichende Zugstabilität aufweisen, um in gestrafftem Zustand die Urethra zu stützen. Ebenso muß das Band eine ausreichende Elastizität aufweisen, um den anatomischen Gewebebewegungen nachgeben und folgen zu können. Um die erforderliche Zugstabilität und Elastizität zu erhalten, ist der textile Verbund des Bandes vorzugsweise als Gewirk ausgeführt, z. B. als in Trikot-, Tuch- und Samtbindung. Die Maschenweite wird dabei so gewählt, dass ein gutes Einwachsen des Bindegewebes in die textile Struktur möglich ist. In einer besonders bevorzugten Ausführung wird das Gewirk in Frottierbindung so ausgeführt, dass sowohl die Primärverhakung als auch das Einwachsen von Gewebe begünstigt wird.The band must have sufficient tensile stability to be able to move in streamlined condition to support the urethra. Likewise, that must Band have sufficient elasticity to the anatomical Give way to tissue movements and be able to follow. To the to obtain the required draft stability and elasticity is the textile composite of the band is preferably designed as a knitted fabric, z. B. as in jersey, cloth and velvet binding. The mesh size is chosen so that a good ingrowth connective tissue into the textile structure is possible. In a particularly preferred embodiment, the knit terry toweling executed so that both the Primärverhakung as also the ingrowth of tissue is favored.
Das Band kann vorwiegend oder ausschließlich aus Monofilen oder auch aus Multifilen gebildet sein. Dabei kann für das gesamte Band das gleiche Filamentmaterial verwenden werden. Besteht das Band aus einem nicht resorbierbaren Material, so verbleibt das Band dauerhaft als stützende Matrix in dem Gewebe. Ist eine ausreichende Bindegewebsproliferation zu erwarten, so kann auch ein resorbierbares Material verwendet werden. Das Band löst sich dann auf und wird resorbiert, wenn das Bindegewebe wieder eine ausreichende Stabilität erlangt hat.The band can be mainly or exclusively monofilament or be formed of multifilaments. It can for the entire Band will use the same filament material. Consists the band of a non-absorbable material, so the band remains permanently as a supporting matrix in the tissue. If adequate connective tissue proliferation is to be expected, so also a resorbable material can be used. The band then dissolves and is reabsorbed if that Connective tissue has again achieved sufficient stability.
Vorzugsweise wird das Band aus zwei oder gegebenenfalls mehr unterschiedlichen Filamentmaterialien hergestellt. Dadurch können die mechanischen Eigenschaften des Bandes optimiert werden. Insbesondere ist es von Vorteil, das Band aus einem resorbierbaren und einem nicht resorbierbaren Filamentmaterial herzustellen. Durch Resorption eines Materials wird die Narbenbildung und damit die dauerhafte Verankerung gefördert. Dies kann durch resorbierbare Filamente oder durch resorbierbare Beschichtung eines nicht oder langsam resorbierbaren Filaments gelöst werden. Insbesondere können dabei die Randfäden aus einem resorbierbaren Material bestehen. Diese Randfäden dienen in erster Linie zur Primärverankerung des Bandes während und nach der Operation. Sobald das Band durch Einsprossen des Bindegewebes dauerhaft verankert ist, können die Kantenfäden resorbiert werden. Dadurch ist eine Gewebsreizung durch die Kantenfäden auf Dauer ausgeschlossen. Weiter kann auch der gesamte textile Verbund des Bandes durch eine Kombination von resorbierbaren und nicht resorbierbaren Filamenten hergestellt werden. Beim operativen Einsetzen kann das Band eine geringe Maschenweite aufweisen, die sich aus den resorbierbaren und den nicht resorbierbaren Filamenten ergibt. Dadurch ist eine hohe Stabilisierungswirkung des Bandes sichergestellt. Durch. das spätere Resorbieren der resorbierbaren Filamente verbleibt das Band dann mit der größeren Stäbchenweite der noch verbleibenden nicht resorbierbaren Filamente, so dass ein gutes Einwachsen des Bindegewebes in das Band begünstigt wird. Eine rauhe Oberfläche z.B. der Frottierbindung oder die vermehrte Narbenbildung durch resorbierbare Fäden kann im Bereich der Blase unerwünscht sein. Dies wird bevorzugt durch eine Veränderung der Bindung über der Implantatlänge gelöst. Z.B. wird der Verankerungbereich durch eine Frottierbindung gebildet, während im Bereich der Blase z.B. eine Trikotbindung oder eine Flottung ausgeführt ist.Preferably, the band of two or more, if necessary produced different filament materials. Thereby can optimize the mechanical properties of the tape become. In particular, it is advantageous to make the tape from a resorbable and a non-absorbable filament material manufacture. Resorption of a material causes scarring and thus promote the permanent anchorage. This can be caused by resorbable filaments or by resorbable Coating of a non or slowly resorbable filament be solved. In particular, the edge threads can consist of a resorbable material. These border threads serve primarily for the primary anchoring of the tape during and after the operation. Once the tape is sprouted connective tissue is permanently anchored, the edge threads be absorbed. This causes a tissue irritation the edge threads permanently excluded. Next can also be the entire textile composite of the band by a combination of absorbable and non-absorbable filaments become. During operative insertion, the band may have a low Have mesh size made up of the resorbable and gives the non-absorbable filaments. This is one high stabilization effect of the tape ensured. By. the subsequent absorption of resorbable filaments remains then tape with the larger stick width of the remaining ones non-absorbable filaments, allowing a good ingrowth connective tissue in the band is favored. A rough surface e.g. terry toweling or the augmented Scarring due to absorbable sutures may be in the range of Bubble be undesirable. This is preferred by a change the bond over the implant length solved. For example, becomes the anchoring area is formed by a terry tie, while in the area of the bladder e.g. a tricot tie or a Fleet is executed.
Grundsätzlich können alle fadenbildenden biokompatiblen Polymere verwendet werden. Dies sind aus der Gruppe der nicht resorbierbaren Polymere namentlich Polyethylen PE, Polypropylen PP, Polyester (z.B. Polyethylenterephthalat PET und Polybutylenterephthalat PBT), Polyvinylidenefluorid PVDF, Polytetrafluorethylen PTFE und andere fluorhaltige Polymere sowie Polyurethane PUR, Polyetherketone und Polyphenylensulfid. Die resorbierbaren Polymere werden bevorzugt aus der Gruppe der alpha- und beta-Hydroxycarbonsäuren gewählt. Vorzugsweise eignen sich kurzzeitig resorbierbare Polymere, wie Polyglykolsäure PGA. Langsam resorbierende Polymere wie Polylactide können ebenfalls eingesetzt werden. Hier ergibt sich ein besonderer Vorteil, wenn das Implantat durch ionisierende Strahlung sterilisiert werden soll. Ebenso sind Co- und Terpolymere untereinander und mit elastifizierenden Komponenten wie Caprolakton und Trimethylencarbonat geeignet. Schließlich eignen sich auch Polyesteramide oder andere resorbierbare biokompatible fadenbildende Polymerwerkstoffe. Die Resorptionszeit dieser Materialen kann mit den bekannten Methoden der ionisierenden Strahlung beeinflußt werden, wobei gleichzeitig eine Sterilisation des zu implantierenden Bandes erfolgt.In principle, all thread-forming biocompatible polymers be used. These are from the group of non-absorbable Polymers namely polyethylene PE, polypropylene PP, polyester (e.g., polyethylene terephthalate PET and polybutylene terephthalate PBT), polyvinylidene fluoride PVDF, polytetrafluoroethylene PTFE and other fluorine-containing polymers as well Polyurethanes PUR, polyether ketones and polyphenylene sulfide. The absorbable polymers are preferably selected from the group of alpha and beta hydroxycarboxylic acids chosen. Preferably suitable Short-term resorbable polymers, such as polyglycolic acid PGA. Slow-absorbing polymers such as polylactides can also be used. Here's a special one Advantage, if the implant sterilized by ionizing radiation shall be. Likewise, copolymers and terpolymers are mutually exclusive and with elastifying components such as caprolactone and trimethylene carbonate suitable. Finally, are also suitable Polyesteramides or other resorbable biocompatible thread-forming Polymer materials. The absorption time of these materials can with the well-known methods of ionizing Radiation are affected, at the same time a sterilization of the band to be implanted.
Die zur Primärverankerung dienenden schlaufenförmig oder hakenförmig herausragenden Kantenfäden würden bei der Operation das Durchziehen des Bandes durch das Gewebe behindern und zu einer zusätzlichen Traumatisierung des Gewebes führen. Daher wird das Band zum Einziehen in das Gewebe vorzugsweise mit einer schlauchförmigen Hülle umschlossen, die nach Platzieren des Bandes leicht entfernt werden kann, wie dies an sich ebenfalls bereits aus der US 5,899,909 bekannt ist. Der Schlauch kann aus jedem kurzzeitig biokompatiblen Material bestehen, zum Beispiel aus einem für die Herstellung von Kathetern verwendeten Material (z.B. Polyamid, Polypropylen, Polyethylen, Polyvinylchlorid). Nach dem Platzieren des Bandes wird die Hülle der Länge nach von dem Band abgezogen. Hierzu kann die Hülle vorzugsweise in dem Mittelbereich ihrer Längserstreckung mit einer Sollbruch-Perforierung versehen sein oder kann als offene Einscheidung um das Band gelegt sein.The primary anchorage serving looped or hooked Outstanding edge threads would be in the operation hampering the passage of the tape through the tissue and to cause additional traumatization of the tissue. Therefore is the tape for insertion into the tissue, preferably with a enclosed tubular casing after placing of the band can be easily removed, as is itself already known from US 5,899,909. The hose may consist of any biocompatible material for a short time, for example, from one used for the manufacture of catheters Material (e.g., polyamide, polypropylene, polyethylene, Polyvinyl chloride). After placing the tape, the Cover removed lengthwise from the tape. For this purpose, the Sheath preferably in the central region of its longitudinal extent be provided with a predetermined breaking perforation or can as open decision to be placed around the band.
Das Band wird vorzugsweise mittels atraumatischer Nadeln durch das Gewebe gezogen. Besonders bevorzugt sind hierbei wiederverwendbare Nadeln. Zur sicheren, ablösbaren und auch intraoperativ handhabbaren Konnektierung des Bandes und der Hülle an den Nadeln sind diese vorzugsweise an den beiden Enden jeweils mit einem Adapter versehen, der mit einem entsprechenden Adapter der Nadeln gekuppelt werden kann. Der Adaptermechanismus kann als Schraubverbindung, Luerlock, Bajonettverriegelung oder Schnappverbindung ausgeführt sein. Er besteht aus einem biokompatiblen Festmaterial, bevorzugt aus einem polymeren Konstruktionswerkstoff, wie z.B. Polyamid, Polyoxymethylen, Polyetherketon, Polypropylen, Polyethylen oder Polyester. Das Band und gegebenenfalls die Hülle sind mit dem Adapter durch Schweißung, Klebung, Klemmung oder einen Schrumpfschlauch verbunden. In einer besonders bevorzugten Ausführung sind die Adapter direkt an das Band und gegebenenfalls die Hülle angespritzt.The band is preferably transmitted by atraumatic needles pulled the tissue. Particularly preferred are reusable Needles. For safe, detachable and also intraoperative manageable connection of the band and the case at the needles these are preferably at the two ends each provided with an adapter with a corresponding Adapter of the needles can be coupled. The adapter mechanism Can be screwed, Luerlock, bayonet lock or snap connection. He insists from a biocompatible solid material, preferably from a polymeric Construction material, such as Polyamide, polyoxymethylene, Polyether ketone, polypropylene, polyethylene or polyester. The tape and possibly the case are with the adapter by welding, gluing, clamping or a shrink tube connected. In a particularly preferred embodiment are the adapters directly to the tape and possibly the Cover molded.
Im Folgenden wird die Erfindung anhand von in der Zeichnung dargestellten Ausführungsbeispielen näher erläutert. Es zeigen
Figur 1- eine erste Ausführung des Bandes,
Figur 2- eine zweite Ausführung des Bandes,
Figur 3- eine dritte Ausführung des Bandes,
Figur 4- eine vierte Ausführung des Bandes und
Figur 5- eine fünfte Ausführung des Bandes.
- FIG. 1
- a first version of the tape,
- FIG. 2
- a second embodiment of the tape,
- FIG. 3
- a third embodiment of the tape,
- FIG. 4
- a fourth version of the band and
- FIG. 5
- a fifth version of the volume.
In dem ersten Ausführungsbeispiel der Figur 1 ist das Band aus
Grundfäden 1 in einer modifizierten Trikotbindung gewirkt. Das
Gewirk wird im Randbereich durch eine weitere Bindung so ergänzt,
dass jeweils Kantenfäden 2 an den beiden Längskanten
des Bandes Schlaufen bilden, die seitlich über die Kante des
Bandes hinausragen. Die Schlaufen der Kantenfäden 2 weisen eine
Öffnungsfläche von etwa 0,02 bis 1,0mm2 auf. Da die Kantenfäden
2 in den Wirkverbund der Grundfäden 1 einbezogen sind,
sind sie fest mit dem Band verbunden. Da die Kantenfäden 2
keine offenen Enden aufweisen, verursachen sie keine Verletzungen
oder Reizungen des Gewebes. Die großen Schlaufen der
Kantenfäden 2'bewirken jedoch eine sichere Primärverankerung
des Bandes beim Einziehen in das Gewebe. Die großen Öffnungen
der Schlaufen der Kantenfäden 2 begünstigen darüber hinaus das
Einwachsen des Gewebes in die Struktur des Bandes und damit
eine dauerhafte Verankerung des Bandes im Gewebe.In the first embodiment of FIG. 1, the band of
In der in Figur 2 dargestellten zweiten Ausführung wird ein textiles Flächengebilde erzeugt, welches dann in einzelne Bänder unterteilt wird. In der Figur 2 sind nur zwei der Bänder zur Erläuterung dargestellt und die weiteren Bänder ergeben sich durch eine periodische Wiederholung der dargestellten Struktur.In the second embodiment shown in Figure 2 is a textile fabric produced, which then in individual bands is divided. In Figure 2, only two of the bands for explanation and the other bands arise by a periodic repetition of the illustrated Structure.
In der zweiten Ausführung sind die Grundfäden 1 als Fransen
ausgebildet, die durch Teilschussfäden 3 zu Bändern verwirkt
sind. Auf diese Weise werden eine Vielzahl von parallel verlaufenden
Bändern erzeugt. Diese Bänder sind dabei durch Verbindungsfäden
4 miteinander zu dem Flächengebilde verbunden.
Um die einzelnen Bänder aus diesem Flächengebilde zu trennen,
werden die Verbindungsfäden 4 zwischen den einzelnen Bändern
längs Trennlinien 5 durchtrennt. Das Durchtrennen der Verbindungsfäden
4 erfolgt vorzugsweise durch Ultraschallschneiden
oder durch Thermoschneiden, wodurch die Schnittkanten der dann
verbleibenden freien Enden der Verbindungsfäden 4 abgerundet
werden.In the second embodiment, the
Nach dem Durchtrennen der Verbindungsfäden 4 und damit dem
Heraustrennen der Bänder, bilden die Verbindungsfäden 4 die
Kantenfäden des Bandes. Die durchtrennten freien Enden dieser
Kantenfäden ragen aus dem Verbund der Bänder heraus und bilden
Haken, die für die Primärverankerung des Bandes wirksam sind.
Die Abrundung der geschnittenen Enden verringert die Reizung
des Gewebes durch diese abstehenden Kantenfäden. Bevorzugt
werden die Verbindungsfäden 4 aus löslichen oder resorbierbaren
Filamenten gebildet.After severing the connecting
Die Verbindungsfäden 4 sind jeweils über einige Maschenreihen
in den Verbund des Bandes gewirkt, bevor sie zu der Kante des
anschließenden Bandes geführt sind. Dadurch sind die Verbindungsfäden
4 durch Abbindung in mehreren Maschenreihen in dem
Gewirk der Bänder gesichert, so dass sie sich auch nach dem
Durchtrennen nicht ohne eine wesentliche mechanische Einwirkung
aus dem Gewirk des Bandes lösen.The connecting
In der in Figur 3 gezeigten dritten Ausführung bilden die
Grundfäden 1 ein Gewirk. Kantenfäden 6 sind in dieses Gewirk
eingebunden und zu großen über die Längskanten des Bandes hinausragenden
Schlaufen ausgeformt. Die Schlaufen der Kantenfäden
6 gewährleisten auch hier eine sichere Primärverankerung,
ohne eine Reizung des Gewebes zu verursachen. Um einen bindungstechnisch
sauberen Rand zu erhalten, sind die Kantenfäden
6 zusätzlich noch durch eine Flottung 7 gesichert.In the third embodiment shown in Figure 3 form the
Basic threads 1 a knitted fabric.
In der in Figur 4 dargestellten vierten Ausführung sind die
Grundfäden 1 in Fileteinzug zu einem wabenförmigen Band verwirkt.
Die jeweils an den Längskanten des Bandes verlaufenden
äussersten Grundfäden bilden Kantenfäden 2, die über den Rand
des Bandes hinausragende Schlaufen mit einer großen rautenförmigen
Öffnung 8 bilden. Diese Schlaufen bewirken eine Primärverankerung
des Bandes im Gewebe und begünstigen das Einwachsen
des Gewebes zur dauerhaften Stabilisierung des Bandes.In the fourth embodiment shown in Figure 4 are the
In der in Figur 5 dargestellten fünften Ausführung sind die
Grundfäden 1 als Fransen ausgebildet. Eine Kombination bestehend
aus Fäden 9 Masch und Schuß wird auf zwischennadeln gelegt,
so dass über die gesamte Breite des Bandes Schlaufen gebildet
werden, die sowohl die Primärverankerung als auch das
dauerhafte Einwachsen des Gewebes begünstigen.In the fifth embodiment shown in Figure 5 are the
Claims (19)
- A tension-free, elastic tape for the surgical treatment of urinary incontinence in women, the textile structure of which makes the ingrowth of connective tissue possible,
characterised in that at its longitudinal edges the tape comprises selvedge threads (2, 4, 6, 8), which for primary anchoring of the tape in the tissue protrude from the fibrous web of the tape and which are securely tied into the structure of the tape. - A tape according to Claim 1,
characterised in that the fibrous web of the tape is designed as a knitted fabric. - A tape according to Claim 2,
characterised in that the knitted fabric is designed in towel weave. - A tape according to one of Claims 1 to 3,
characterised in that the tape is predominantly or exclusively made from monofilaments. - A tape according to one of Claims 1 to 3,
characterised in that the tape is predominantly formed of multifilaments. - A tape according to one of Claims 1 to 5,
characterised in that the tape is manufactured from non-absorbable material. - A tape according to one of Claims 1 to 5,
characterised in that the tape is produced from at least two different filament materials. - A tape according to Claim 7,
characterised in that at least one of the filament materials is absorbable. - A tape according to Claim 8,
characterised in that the selvedge threads (2, 4, 6, 8) are made from absorbable filament material. - A tape according to one of Claims 1 to 9,
characterised in that the selvedge threads (2, 6, 8) take the form of loops, which are tied into the textile structure of the tape. - A tape according to one of Claims 1 to 9,
characterised in that the selvedge threads (4) protrude by their free ends from the composite tape and are tied or anchored into the structure of the tape. - A tape according to Claim 11,
characterised in that several mutually parallel tapes are produced as textile fabric,
in that the tapes in this textile fabric are connected to each other by connecting threads (4)
and in that the connecting threads (4) are cut through to separate the tapes and after being cut through protrude as selvedge threads from the composite tape. - A tape according to Claim 12,
characterised in that the free ends of the connection threads (4) are rounded off during the cutting-through process. - A tape according to one of the preceding Claims,
characterised in that the selvedge threads (6) are secured by a float stitch (7). - A tape according to one of the preceding Claims,
characterised in that the tape is surrounded by an easily removable casing for surgical retraction into the tissue. - A tape according to Claim 15,
characterised in that the tape and possibly the casing are provided at both ends with adapters, which make possible an easily releasable connection with a preferably reusable introducer. - A tape according to Claim 16,
characterised in that the external diameter of the adapter corresponds to the external diameter of the introducer at the connection site. - A tape according to Claim 16 or 17,
characterised in that the tape and possibly the casing are fixed to the adapters by welding, gluing, clamping and/or by means of a heat-shrinkable tube or are sprayed onto them. - A tape according to Claim 16,
characterised in that the adapter can be connected to the introducer by means of a screw connection, Luer lock, bayonet catch or snap connection.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10107521 | 2001-02-17 | ||
DE10107521A DE10107521A1 (en) | 2001-02-17 | 2001-02-17 | Tensile elastic band |
PCT/EP2002/001295 WO2002065944A1 (en) | 2001-02-17 | 2002-02-08 | Tension-free elastic tape |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1361834A1 EP1361834A1 (en) | 2003-11-19 |
EP1361834B1 true EP1361834B1 (en) | 2005-04-27 |
Family
ID=7674426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02718107A Expired - Lifetime EP1361834B1 (en) | 2001-02-17 | 2002-02-08 | Tension-free elastic tape |
Country Status (8)
Country | Link |
---|---|
US (2) | US7901415B2 (en) |
EP (1) | EP1361834B1 (en) |
AT (1) | ATE293933T1 (en) |
CA (1) | CA2438556C (en) |
DE (2) | DE10107521A1 (en) |
DK (1) | DK1361834T3 (en) |
ES (1) | ES2242007T3 (en) |
WO (1) | WO2002065944A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2340769A2 (en) | 2009-12-31 | 2011-07-06 | Aesculap AG | Implant, in particular for treating urinary incontinence, method for producing same and surgical set |
CN108625034A (en) * | 2018-05-01 | 2018-10-09 | 章进通 | A kind of PE cladding fabric and preparation method thereof |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2811218B1 (en) | 2000-07-05 | 2003-02-28 | Patrice Suslian | IMPLANTABLE DEVICE FOR CORRECTING URINARY INCONTINENCE |
US8167785B2 (en) | 2000-10-12 | 2012-05-01 | Coloplast A/S | Urethral support system |
GB0025068D0 (en) | 2000-10-12 | 2000-11-29 | Browning Healthcare Ltd | Apparatus and method for treating female urinary incontinence |
US20060205995A1 (en) | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
DE10107521A1 (en) * | 2001-02-17 | 2002-09-05 | Inst Textil & Faserforschung | Tensile elastic band |
GB0108088D0 (en) | 2001-03-30 | 2001-05-23 | Browning Healthcare Ltd | Surgical implant |
DE10231975A1 (en) * | 2002-07-15 | 2004-02-05 | Serag-Wiessner Kg | Implantable textile fabric |
CA2492630C (en) | 2002-08-02 | 2009-01-13 | C.R. Bard, Inc. | Self anchoring sling and introducer system |
DE10245076B4 (en) * | 2002-09-27 | 2004-09-02 | Riek, Siegfried, Dr.med. | Instruments and procedures for the operative treatment of female urinary incontinence |
GB0307082D0 (en) | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
GB0411360D0 (en) | 2004-05-21 | 2004-06-23 | Mpathy Medical Devices Ltd | Implant |
WO2006106975A1 (en) * | 2005-03-31 | 2006-10-12 | Seiren Co., Ltd. | Warp knitted fabric and method of manufacturing the same |
FR2884706B1 (en) * | 2005-04-22 | 2008-04-04 | Sofradim Production Sa | PROTHETIC KNIT FOR SUPPORT IMPLANTS |
DE102005021893A1 (en) * | 2005-05-04 | 2006-11-09 | Aesculap Ag & Co. Kg | Device for the prevention of urinary incontinence in humans |
GB0613653D0 (en) * | 2006-07-11 | 2006-08-16 | Mpathy Medical Devices Ltd | Tissue regeneration repair device |
US8257245B2 (en) * | 2006-07-21 | 2012-09-04 | Specialties Remeex International, S.L. | Adjustable sling as a support of internal organs or anatomical tissues |
FR2906131B1 (en) * | 2006-09-21 | 2009-04-24 | Cl Medical Sarl | SURGICAL TREATMENT FOR TREATMENT OF URINARY INCONTINENCE IN MAN |
JP2010524635A (en) | 2007-04-28 | 2010-07-22 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | Dynamic and adjustable support equipment |
US20090187197A1 (en) * | 2007-08-03 | 2009-07-23 | Roeber Peter J | Knit PTFE Articles and Mesh |
US20090036996A1 (en) * | 2007-08-03 | 2009-02-05 | Roeber Peter J | Knit PTFE Articles and Mesh |
AU2008287326A1 (en) * | 2007-08-14 | 2009-02-19 | Curant, Inc. | Devices for supporting, elevating, or compressing internal structures |
FR2919996B1 (en) * | 2007-08-17 | 2010-09-10 | Cl Medical | IMPLANT FOR SUPPORTING THE URETRE OF A MAN AND SURGICAL ASSEMBLY FOR TREATMENT OF URINARY INCONTINENCE IN A MAN COMPRISING SUCH AN IMPLANT |
DE102007058256A1 (en) * | 2007-11-26 | 2009-05-28 | Aesculap Ag | Surgical thread mesh |
DE102011007844A1 (en) * | 2011-04-21 | 2012-10-25 | Aesculap Ag | Medical product and process for its preparation |
CN104168840B (en) | 2012-02-23 | 2018-10-16 | 西北大学 | Improved suture |
US10278694B2 (en) | 2012-02-23 | 2019-05-07 | Northwestern University | Indirect attachment of a needle to a mesh suture |
US10123862B2 (en) | 2013-03-14 | 2018-11-13 | Ethicon, Inc. | Randomly uniform three dimensional tissue scaffold of absorbable and non-absorbable materials |
US9352071B2 (en) | 2013-03-14 | 2016-05-31 | Ethicon, Inc. | Method of forming an implantable device |
KR101982704B1 (en) * | 2017-11-24 | 2019-05-27 | 한솔에코 주식회사 | Method Of Producing Tircot Textiles Having Excellent ventolation |
CN109576891B (en) * | 2019-01-27 | 2021-12-07 | 广东扬帆网业有限公司 | Small-mesh warp knitting knotless net piece and knitting method thereof |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3124136A (en) * | 1964-03-10 | Method of repairing body tissue | ||
DE466736C (en) * | 1928-10-12 | F A Schurig Fa | Device for looms for the manufacture of ribbons with fringes | |
US1428465A (en) * | 1919-02-04 | 1922-09-05 | William H Horn & Brother Inc | Kneecap or elbow bandage |
US1518798A (en) * | 1923-04-23 | 1924-12-09 | Kendrick Thomas Frank | Elastic fabric |
US1533544A (en) * | 1923-08-25 | 1925-04-14 | James R Kendrick Co Inc | Fabric and art of producing same |
US1867183A (en) * | 1929-01-18 | 1932-07-12 | Simons Paul | Insulating tape |
US1772955A (en) * | 1929-03-28 | 1930-08-12 | Moore Fab Co | Curvilinear elastic fabric |
US1949318A (en) * | 1930-05-30 | 1934-02-27 | Markowsky Fritz | Footwear |
US1950559A (en) * | 1931-05-28 | 1934-03-13 | United Elastic Corp | Elastic woven fabric |
US1887927A (en) * | 1932-05-12 | 1932-11-15 | James R Kendrick Co Inc | Elastic fabric |
US3190289A (en) * | 1963-02-05 | 1965-06-22 | Kendall & Co | Surgical sponge |
AT326803B (en) * | 1968-08-26 | 1975-12-29 | Binder Fa G | MESHWARE AND METHOD OF MANUFACTURING THE SAME |
US3618754A (en) * | 1969-02-11 | 1971-11-09 | Kendall & Co | Conformable elastic adhesive tape |
US3787272A (en) * | 1969-12-29 | 1974-01-22 | Carolina Narrow Fab Co | Glass fabric suitable for casts, bandages, and the like |
CH590355A5 (en) * | 1974-12-19 | 1977-08-15 | Mueller Jakob | |
US3965703A (en) * | 1975-04-18 | 1976-06-29 | Southern Webbing Mills | Warp knitted compression bandage fabric |
JPS5547861A (en) * | 1978-10-04 | 1980-04-05 | Tokyo Eizai Lab | Fixed bandage |
US4452245A (en) * | 1980-06-06 | 1984-06-05 | Usher Francis C | Surgical mesh and method |
JPS6285113U (en) * | 1985-11-15 | 1987-05-30 | ||
US4792336A (en) * | 1986-03-03 | 1988-12-20 | American Cyanamid Company | Flat braided ligament or tendon implant device having texturized yarns |
US4839215A (en) * | 1986-06-09 | 1989-06-13 | Ceramed Corporation | Biocompatible particles and cloth-like article made therefrom |
US4733545A (en) * | 1987-06-04 | 1988-03-29 | Collins & Aikman Corporation | Ravel resistant warp knit elastic tape and method |
EP0511452B1 (en) * | 1991-04-30 | 1996-07-10 | CINTEL S.a.s. di Fontana Paola & C. | Elastic support element or belt for stuffing of furniture pieces or car seats |
US5456711A (en) * | 1992-05-15 | 1995-10-10 | Intervascular Inc. | Warp knitted carotid patch having finished selvedged edges |
US5265445A (en) * | 1992-09-01 | 1993-11-30 | Shytles Douglas M | Breathable elastic fabric and method of making same |
JP2563369Y2 (en) * | 1992-09-21 | 1998-02-18 | ワイケイケイ株式会社 | Warp knit base fabric for hook-and-loop fastener |
US5512354A (en) * | 1993-01-25 | 1996-04-30 | Minnesota Mining And Manufacturing Company | Fabric backing for orthopedic support materials |
US5455060A (en) * | 1993-10-25 | 1995-10-03 | Minnesota Mining And Manufacturing Company | Compacted fabrics for orthopedic casting tapes |
US5458636A (en) * | 1994-07-20 | 1995-10-17 | U.S. Biomaterials Corporation | Prosthetic device for repair and replacement of fibrous connective tissue |
US5522240A (en) * | 1994-08-15 | 1996-06-04 | Matrex Furniture Components, Inc. | Furniture elastic webbing and method |
US5899909A (en) * | 1994-08-30 | 1999-05-04 | Medscand Medical Ab | Surgical instrument for treating female urinary incontinence |
GB9510624D0 (en) * | 1995-05-25 | 1995-07-19 | Ellis Dev Ltd | Textile surgical implants |
US5569273A (en) * | 1995-07-13 | 1996-10-29 | C. R. Bard, Inc. | Surgical mesh fabric |
US5885910A (en) * | 1997-01-08 | 1999-03-23 | Lace Lastics Company, Inc. | Non-slip knitted lace fabric and method of manufacturing same |
WO1998041154A1 (en) * | 1997-03-20 | 1998-09-24 | Focal, Inc. | Biodegradable tissue retractor |
DE19832634A1 (en) * | 1998-07-09 | 2000-01-13 | Ethicon Endo Surgery Europe | Multilayer flat implant especially for hernia treatment |
US6547820B1 (en) * | 2000-10-03 | 2003-04-15 | Scimed Life Systems, Inc. | High profile fabric graft for arteriovenous access |
US20020128670A1 (en) * | 2000-11-22 | 2002-09-12 | Ulf Ulmsten | Surgical instrument and method for treating female urinary incontinence |
JP3490070B2 (en) * | 2000-12-05 | 2004-01-26 | 健一 横山 | Stretch fabric material for medical use |
DE10107521A1 (en) * | 2001-02-17 | 2002-09-05 | Inst Textil & Faserforschung | Tensile elastic band |
DE10231975A1 (en) * | 2002-07-15 | 2004-02-05 | Serag-Wiessner Kg | Implantable textile fabric |
-
2001
- 2001-02-17 DE DE10107521A patent/DE10107521A1/en not_active Ceased
-
2002
- 2002-02-08 CA CA2438556A patent/CA2438556C/en not_active Expired - Fee Related
- 2002-02-08 DE DE50202911T patent/DE50202911D1/en not_active Expired - Lifetime
- 2002-02-08 AT AT02718107T patent/ATE293933T1/en active
- 2002-02-08 EP EP02718107A patent/EP1361834B1/en not_active Expired - Lifetime
- 2002-02-08 US US10/468,188 patent/US7901415B2/en not_active Expired - Fee Related
- 2002-02-08 ES ES02718107T patent/ES2242007T3/en not_active Expired - Lifetime
- 2002-02-08 WO PCT/EP2002/001295 patent/WO2002065944A1/en not_active Application Discontinuation
- 2002-02-08 DK DK02718107T patent/DK1361834T3/en active
-
2011
- 2011-01-28 US US13/016,321 patent/US8152857B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2340769A2 (en) | 2009-12-31 | 2011-07-06 | Aesculap AG | Implant, in particular for treating urinary incontinence, method for producing same and surgical set |
DE102009060802A1 (en) | 2009-12-31 | 2011-07-07 | Aesculap AG, 78532 | Implant, in particular for the treatment of urinary incontinence, process for its preparation and surgical set |
CN108625034A (en) * | 2018-05-01 | 2018-10-09 | 章进通 | A kind of PE cladding fabric and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
US8152857B2 (en) | 2012-04-10 |
US7901415B2 (en) | 2011-03-08 |
DK1361834T3 (en) | 2005-08-29 |
US20110130623A1 (en) | 2011-06-02 |
DE50202911D1 (en) | 2005-06-02 |
EP1361834A1 (en) | 2003-11-19 |
CA2438556A1 (en) | 2002-08-29 |
CA2438556C (en) | 2010-04-13 |
ES2242007T3 (en) | 2005-11-01 |
WO2002065944A1 (en) | 2002-08-29 |
ATE293933T1 (en) | 2005-05-15 |
DE10107521A1 (en) | 2002-09-05 |
US20040144394A1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1361834B1 (en) | Tension-free elastic tape | |
EP1099421B1 (en) | Prosthetic patch and method of manufacture | |
DE60029684T2 (en) | Surgical knitted fabrics | |
DE60108818T2 (en) | Reinforced submucosal layer of the small intestine | |
EP2229109B1 (en) | Surgical suture material consisting of braided thread | |
EP1411997B1 (en) | Textile implant made of monofil threads from polyvinyl fluoride | |
DE10120942B4 (en) | Abdominal wall reinforcement | |
DE19942611C1 (en) | Reinforced flat implant | |
DE60020350T2 (en) | SURGICAL KNITTING TISSUE | |
DE60007730T2 (en) | TREATMENT DEVICE FOR PROLAPSUS BY SUPPORTING VAGINA | |
DE10231975A1 (en) | Implantable textile fabric | |
DE102008057213A1 (en) | Medical device product, a surgical kit and a manufacturing process for the medical device product | |
DE10219860A1 (en) | Surgical thread and surgical implant with such a thread | |
DE102011007844A1 (en) | Medical product and process for its preparation | |
DE102005012555A1 (en) | Surgical implant | |
DE102009020897A1 (en) | Thread with coated anchoring structures for anchoring in biological tissues and a method for its production | |
US20080127682A1 (en) | Disassemble covering | |
DE102009020894A1 (en) | Elastomeric thread with anchoring structures for anchoring in biological tissues | |
EP2340784B1 (en) | Textile net, in particular for prolapse treatment and care for or preventing dyspareunia | |
EP2340769B1 (en) | Implant, in particular for treating urinary incontinence, method for producing same and surgical set | |
DE102008044005A1 (en) | Planar implant for in abdominal wall region of patient during hernia surgery, has threads with cellular arrangement made in connecting area, where thread aligned parallel to cutting direction, is not present in wound area | |
DE102004062444B4 (en) | Incontinence band for use in surgery in the treatment of urinary incontinence | |
DE60319257T2 (en) | COMPOSITE INTERMEDIATE FOR THE PRODUCTION OF A PROSTHESIS | |
DE3323430A1 (en) | Implant for bridging defects in the spinal cord or in peripheral nerves | |
DE102010023413A1 (en) | Textile net implant for supplying incisional hernia during open or laparoscopic surgical intervention to e.g. close hernial opening, has overlay pattern comprising pattern elements movably arranged parallel to each other |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030802 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50202911 Country of ref document: DE Date of ref document: 20050602 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050727 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: R. A. EGLI & CO. PATENTANWAELTE |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20050810 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20051010 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2242007 Country of ref document: ES Kind code of ref document: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060228 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060228 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060228 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
ET3 | Fr: translation filed ** decision concerning opposition | ||
26N | No opposition filed |
Effective date: 20060130 |
|
BERE | Be: lapsed |
Owner name: DEUTSCHE INSTITUTE FUR TEXTIL- UND FASERFORSCHUNG Effective date: 20060228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050427 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20180221 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20180221 Year of fee payment: 17 Ref country code: ES Payment date: 20180322 Year of fee payment: 17 Ref country code: FI Payment date: 20180216 Year of fee payment: 17 Ref country code: GB Payment date: 20180221 Year of fee payment: 17 Ref country code: DK Payment date: 20180221 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20180226 Year of fee payment: 17 Ref country code: AT Payment date: 20180220 Year of fee payment: 17 Ref country code: TR Payment date: 20180207 Year of fee payment: 17 Ref country code: IT Payment date: 20180221 Year of fee payment: 17 Ref country code: SE Payment date: 20180222 Year of fee payment: 17 Ref country code: IE Payment date: 20180220 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20180327 Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 50202911 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20190228 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20190301 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 293933 Country of ref document: AT Kind code of ref document: T Effective date: 20190208 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20190208 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190209 Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190208 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190208 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190228 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190208 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190228 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190301 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190208 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190903 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190228 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190208 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20200327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190209 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190208 |